Podcasts about medical science liaison msl

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

In this episode of The Happy PharmD podcast, we have the privilege of introducing Julie Tuccillo-Stracener, a seasoned pharmacist with over a decade of experience who has transitioned into the role of a Medical Science Liaison (MSL). Julie's extensive background in pharmacy positions her uniquely in her current role, where she brings a wealth of clinical knowledge to bridge the gap between science and healthcare.   Join us as we delve into Julie's remarkable career, exploring her journey and the insights she brings as a dedicated MSL. Here are the highlights of my conversation with Julie: 04:51 - The triggers that led Julie to consider a career change, including a negative incident at work and a conversation with a parent at her kid's dentist's office. 09:40 - The timing of Julie's engagement with the Happy PharmD and her commitment to exploring different career paths. 23:07 - Julie discusses how her perfectionism and imposter syndrome affected her career journey, especially regarding the travel component of the MSL role. 34:47 - The importance of networking and building connections in her successful journey to securing an MSL role. 37:39 - Julie's seamless fit into the MSL role, her identified strengths, transition to a new industry, and potential benefits, including higher salary and bonuses. 46:14 - Securing an MSL role without a residency and the importance of clinical experience. 52:17 - An explanation of the "Final Dose" strategy, emphasizing the opportunity to reiterate main points and demonstrate commitment. 58:49 -  The positive impact of Julie's new role on her family life, including more time with her children and reduced stress.   Links: Julie's LinkedIn - https://www.linkedin.com/in/julie-tuccillo/   We get pharmacists jobs they love! If you are ready to find your dream job and enjoy a balanced work and home life, we want to connect with you.    Click the link below to book a free call with us! https://thehappypharmd.com/HPDPodcast  

Special Episode: Travel with us in this journey through the fascinating world of Medical Science Liaison (MSL), new career path for pharmacists! Get firsthand knowledge from the CEO of The MSL Society and how to break into the amazing career path. We are giving away a signed copy of the book "The Medical Science Liaison Career Guide: How to Break Into Your First Role". To the one lucky aspiring MSL, please share our podcast link, tag Becky, Behnaz, and Samuel Dyer and make sure to use the hashtag PGx4Rx to be entered into the contest. The winners will be announced in the first week of January 2024. Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.

Special Episode: Travel with us in this journey through the fascinating world of Medical Science Liaison (MSL), new career path for pharmacists! Get firsthand knowledge from the CEO of The MSL Society and how to break into the amazing career path. We are giving away a signed copy of the book "The Medical Science Liaison Career Guide: How to Break Into Your First Role". To the one lucky aspiring MSL, please share our podcast link, tag Becky, Behnaz, and Samuel Dyer and make sure to use the hashtag PGx4Rx to be entered into the contest. The winners will be announced in the first week of January 2024.  Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.  

Nabhan Islam is a Medical Science Liaison (MSL) in the biotech industry, based in beautiful Vancouver, BC. As a perennial traveller and outdoor gear nut, Nabhan always has an eye for durable, well-designed gear that makes his life easier and more enjoyable.   TOOLS:  0:00 - Intro 0:54 - Victorinox Cadet Swiss Army Knife: https://www.victorinox.com/us/en/Products/Swiss-Army-Knives/Medium-Pocket-Knives/Cadet-Alox/p/0.2601.26 6:14 - MSR reactor stove system: https://www.msrgear.com/ca/stoves/stove-systems/reactor-stove-systems/reactor-stove-systems.html 17:03 - Helinox Chair Zero: https://helinox.com/products/chair-zero?variant=16664192286790 23:53 - Fjallraven backpack: https://www.fjallraven.com/us/en-us/bags-gear/backpacks-bags/daypacks/high-coast-rolltop-26   Watch on YouTube: https://youtu.be/gSmKDOkODsM For show notes and transcript visit: https://kk.org/cooltools/nabhan-islam-medical-science-liaison/ To sign up to be a guest on the show, please fill out this form: https://forms.gle/qc496XB6bGbrAEKK7  

In this special episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD interviews three of Lumanity Medical Affairs Consulting PharmDs, Stephanie Wong, George Shyu, and Chris Maclafferty. They discuss the different paths they took from earning their degree to joining the pharmaceutical industry as well as the additional training and knowledge they felt were required to be successful in Medical Affairs. They breakdown the skills and expertise that PharmDs can bring to a Medical Affairs organization and how they chose to work in a consulting role rather than in a more typical role as a Medical Science Liaison (MSL) or Medical Information Specialist. They wrap up by describing the different types of consulting work they find most fulfilling and how they “stay curious” and grow their careers.

Matteo Ottolini , Medical Science Liaison (MSL) at Bayer Pharmaceuticals discusses how he was able to land his first MSL role  in the US as an international candidate Matteo shares….

The Medical Science Liaison (MSL) in the pharmaceutical industry is a popular position for physicians who wish to leave clinical practice. This is true because it is possible to qualify for the job regardless of the extent of training (i.e., whether residency-trained or board certified, or not) or specialty; it does not require special certifications or degrees (beyond a medical degree); and it provides a moderate amount of flexibility to work part of the time from home. However, it often involves traveling to meet with clients up to 60% of the time. John created a six-lesson course called How to Secure a Career as a Medical Science Liaison for the Nonclinical Career Academy. And he has taken excerpts from that course for PNC Podcast Episodes 276 and 277. By presenting the pros and cons, and an overview of the steps you can take to prepare for a job as an MSL, you will gain a much deeper understanding of the position and whether to pursue it. He also goes into detail about common tactics used to find a nonclinical career, including converting your CV to a resumé, engaging mentors; networking effectively, creating a LinkedIn profile, and identifying professional organizations that can hasten your progress. The course can be found at: https://nonclinicalphysicians.com/mslcourse. You will find links mentioned in the episode at https://nonclinicalphysicians.com/captivating-career-as-an-msl. NewScript, a Community of clinicians writing a new script for their careers and lives, is accepting new members. The easiest way to check it out is to go to nonclinicalphysicians.com/newscript. The monthly fee of under $5 is locked in for life. However, the fee will be going up to $7.99 per month on Sunday, December 11, 2022. So, get all of the fantastic resources and join a community of like-minded healthcare professionals by going to nonclinicalphysicians.com/newscript TODAY before the monthly fee increases.                                                            =============== You can support this podcast by making a small monthly or annual donation. To learn more, go to nonclinicalphysicians.com/donate You can now join the most comprehensive Community for all clinicians looking for a nontraditional career at NewScr!pt. Get an updated edition of the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. Check out a FREE WEBINAR called Best Options for an Interesting and Secure Nonclinical Job at nonclinicalphysicians.com/freewebinar1

With the pharmaceutical industry becoming more and more heavily competitive, knowing how to conduct an insightful and multidimensional assessment of your Medical Science Liaison (MSL) team to identify gaps and hire the right MSLs to not only accelerate a corporate competitive advantage, but also to cultivate the natural diversity of a proper team for internal peer-to-peer development and external stakeholder rapport is more critical than ever.   With an extensive and influential career in Medical Affairs (MA) at Sanofi Pasteur spanning more than two decades starting in the field and now the current Senior Director of the Field Medical Team in the Vaccines therapeutic unit at Sanofi Pasteur, Christina Tankersley, PharmD has mastered the know-how of building, training, and maturing a diverse, multidisciplinary MSL team. She joins Dr. Peg Crowley-Nowick, Founder and President of Zipher Medical Affairs on this inaugural podcast of the second season of Zipher Medical Affairs Unscripted to share her invaluable experience on how to intentionally identify key diversities needed in constructing a balanced and symbiotic MSL team, and how to overcome the challenges of unifying team members across the now common virtual office settings. Dr. Crowley-Nowick also draws on Dr. Tankersley's vast experience and innate propensity for coaching and mentoring to discuss the possible pitfalls of the industry's current trend in condensing the onboarding experience for MSLs and potentially driving MSLs into the field prematurely and asks her to expound on her innovative approach for onboarding. Lastly, Dr. Tankersley characterizes the fundamental cornerstone of an MSL development plan and fostering actions to support that vision.

During pharmacy school, the husband of one of Elaine's professors was a Medical Science Liaison (MSL). She jumped at the opportunity to meet him and asked questions about his role, fellowships, and industry in general—and that important conversation solidified her decision to pursue an industry career. One of the greatest pieces of advice that Elaine offers listeners is to always "raise your hand." She launched her career working for a small company, and as long as she was meeting her goals, she would often volunteer for new projects and opportunities that helped her grow personally and professionally. Tune in to learn how to develop industry "soft skills" not taught in pharmacy school, an overview of field medical, how to decide between a small or large company, and much more. A special thank you to our episode sponsor, Keck Graduate Institute (KGI)! https://www.kgi.edu/academics/schools/school-of-pharmacy-and-health-sciences/

In today's episode we're joined by the Dr. Henry Henderson, PhD. Henry is a native of Mobile, AL and currently resides in Atlanta, GA. He received his B.S. from Southern University and A&M College and his Ph.D. in Integrative Biosciences with a concentration in cancer biology from Tuskegee University. Following his graduate studies, he completed his postdoctoral training at Vanderbilt University Medical Center where he also served as an FDA-AACR Oncology Educational Fellow. Currently, Dr. Henderson is currently an oncology Medical Science Liaison (MSL) in the cancer diagnostics sector and aspires to become a medical affairs executive. Tune in as we discuss everything from what an MSL is to the value in creating a backwards timeline to develop your career. Dr. Henderson is a major proponent of sharing his professional aspirations and career journey publicly, and not moving in silence or keeping it to himself. It's all about representation and exposure, right? It's one of the reasons he and co-founder Sigourney Bell, created Black in Cancer. Be sure to check out this engaging and illuminating episode and check out all the wonderful things that Black in Cancer is doing. As always, please continue to like, share, and comment on this podcast and others. We'd love to hear from you. Twitter: @FTCPodcast421 / @fortheculturepod - IG/LinkedIn @Blackincancer @DrHJHenderson

Hosts: Fady Abdlrasul, PharmD & Kristen Longstreth, PharmD, BCPS Guest: Travis Macek, PharmD, BCPS Summary: In this episode, Fady and Kristen interview Travis Macek, PharmD, BCPS. Dr. Macek is a Senior Medical Science Liaison for AbbVie . Travis graduated from Northeast Ohio Medical University in 2016 before pursuing two years of residency training. He completed his PGY-1 Pharmacy Practice residency at St. Elizabeth Youngstown Hospital in Youngstown, Ohio before moving to Raleigh, North Carolina to complete a PGY-2 in Critical Care Medicine at WakeMed Health and Hospitals. Upon completion of his PGY-2, Travis took a job as a Medical Science Liaison (MSL) at AbbVie, focusing on the research and development of medications in the gastrointestinal space. Recently, Travis has taken a position as a Senior MSL in the hematologic malignancy space at AbbVie, which will grant him more exposure to pipeline medication development and launch support. In this episode, Travis talks to us about the pillars of being a medical science liaison, what a typical work week looks like, the difference between being an MSL and a drug rep, and much more!  Thank you for listening! NEOMED College of Pharmacy: https://www.neomed.edu/pharmacy/academics/pre-pharmacy/  @neomedcop on Facebook, Instagram, Twitter, TikTok, & LinkedIn Credits:  Music from Uppbeat (free for Creators!): https://uppbeat.io/t/zoo/clarity  License code: LIDMGHYBZGHXNEJI

On this episode we have Dr. Lewerenzii who gives us a unique perspective of a physician working in a non-clinical position. Dr. Lewerenzii studied and graduated from Kirksville College of Osteopathic Medicine, now better known as A.T. Still University. He completed his residency in family medicine and after 10 years of practicing decided he wanted to do something different. Dr. Lewerenzii tells his experience and path to becoming a Medical Science Liaison (MSL) where he works to bridge the gap between healthcare workers in the field and the pharmaceutical industry. As an MSL, he has worked under multiple disciplines including rheumatology, dermatology and now GI. This episode will give pre-medical and medical students the opportunity to explore unique careers and roles while still being a physician. 

In this episode, we interview Dr. Danyelle Martin, a Medical Science Liaison (MSL) at Moderna, in order to learn more about the what, how, and future of mRNA-based therapeutics, and what impact it can have on healthcare and healthcare professionals in general. Key Concepts Moderna has a “Research Engine” proprietary service that takes an mRNA idea from a web-based digital designer, to a digital ordering system, and finally to a production facility where mRNA constructs are synthesized and quality tested. Pharmaceutics play a big role in the formulation of mRNA particles. Lipid nanoparticles (LNPs) play an important role for stability and delivery of mRNA cargo. After LNPs and mRNA are co-formulated, the product is purified, filtered, frozen, and subjected to a series of good manufacturing practice (GMP) tests to ensure product quality. COVID-19 vaccines are a small glimpse into the potential future of mRNA-based therapeutics. Moderna's pipeline includes mRNA vaccines for other viruses (including RSV, influenza, Zika and CMV) as well as therapeutics for non-viral diseases (including a personalized cancer vaccine and a VEGF-A mRNA molecule for myocardial ischemia).

¿Qué es un MSL?En colaboración con la Sociedad Española de Bioquímica y Biología Molecular-SEBBM, en este episodio conoceremos de manera informal qué es un MSL y cuál es la realidad profesional y el día a día de un Medical Science Liaison.Invitados:- Martina Riosalido- MSL Oncología, medicina nuclear y gastroenterología (Norgine)- Andrés Madrona- MSL Cardiometabolismo (Novartis)- Álvaro Herrera- MSL Onco-hematología y enfermedades raras (EUSA Pharma)- Daniela Rossi- MSL Neurología (Eisai farmacéutica)Anfitriones:- Paula Mera (Sociedad Española de Bioquímica y Biología Molecular-SEBBM)- Manolo Castellano (Carreras Científicas Alternativas)Contáis con la versión de video de esta sesión en nuestro canal de YouTube: https://youtu.be/wcv3pOyhIW4 ---https://carrerascientificasalternativas.com/podcast-entrevistas/

Learn the exact steps MSLs can take to plan for KOL meetings to ensure meeting objectives are strategical aligned to the overall brand strategy. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter.Learn more about 1:1 MSL coaching here: https://www.mslconsultant.com/msl-training

This episodes describes how an MSL works cross functionally with other members of the pharmaceutical company and types of projects MSLs can collaborate with other team members on. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter. Need help working with your cross functional colleagues? Email info@mslconsultant.com to find out about my 1:1 coaching for MSLs.

Three steps for effectively organising an advisory board. Tips on running a virtual advisory board. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter. Email info@mslconsultant.com if you need help running an advisory board.

KOL stakeholder mapping is one of the most important functions of an MSL and identifying the right KOLs can add huge value to the pharmaceutical company. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter.

MSL Interview process is broken down into three stages: phone interview with HR, face the face interview with hiring manager and clinical paper or 90 day plan presentation. This episode explains how to pass each stage of the interview process. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter.

This episode explains how to define an MSL (the most common interview question!), Who MSLs work with and their daily roles and responsibilities. Brought to you by MSL Consultant Newsletter. Sign up here: https://www.mslconsultant.com/newsletter.

The Medical Science Liaison (MSL) has gone through a bit of an identity overhaul. A role that used to lean almost exclusively on scientific acumen must now more than ever also rely on business chops and people skills.  A shift akin to moving from Geek Squad…to Apple Genius Bar.Keith Morris, Executive Managing Director, Medical Affairs at Syneos Health Consulting, and Ric Phipps, Senior Vice President, Global Field Medical Affairs for Syneos Health Deployment Solutions discuss the increased complexity of the role of as the needs of today's customer groups are evolving and how, as a result, the required competencies and skillsets of these field teams have changed.For more episodes on Medical Affairs:Medical Affairs from ZeroMA “Squared”: Medical Affairs Meets Market AccessMedical Affairs Series, Part One – A Foundation for Medical AffairsMedical Affairs Series, Part Two – Measuring the Unmeasurable: Medical Affairs MetricsMedical Affairs Series, Part Three – Moving to the LeftLike what you're hearing?  Be sure to rate and review us!  We want to hear from you!  If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com. 

The role of Medical Affairs has changed dramatically in China over the last 10-15 years, moving from what was once considered a secondary support function to one now at the forefront of a more patient-centric paradigm.Sam Ying, Vice President and General Manager for Syneos Health Commercial in China, discusses the evolution of the Medical Affairs function in China, the rise of the Medical Science Liaison (MSL) and other customer-facing roles, and the importance of digital transformation in the region.Like what you're hearing?  Please be sure to subscribe, rate and review us!

En este episodio hablaremos de los procesos de transición profesional para los científicos que ya no son tan jóvenes. Comentaremos la aparición del CV ciego y del efecto de quitar la edad en el curriculum. Además, insistiremos en la importancia de la formación continua a cualquier edad para la mejora de la empleabilidad.En este episodio entrevistamos a José Ignacio Piruat, Medical Science Liaison (MSL) de una gran empresa farmaceutica.https://carrerascientificasalternativas.com/podcast/ Si tienes algún comentario sobre este episodio o ideas para futuros programas, no dudes en escribirnos a "info@carrerascientificasalternativas.com"

Breaking Down the BCMAS Certification: A Conversation with Dr. William Soliman of ACMA An experienced executive with several years of experience in the pharmaceutical and biotechnology industry, Dr. Soliman has held key positions within medical affairs where he was instrumental in launching a variety of innovative platforms expanding the role of medical affairs across the industry. He is currently the President of the Accreditation Council for Medical Affairs (ACMA). Dr. Soliman is often invited to speak at important pharmaceutical industry conferences focusing on medical affairs, patient navigation and its relationship to field based medical teams, and the ever-changing role of the medical science liaison (MSL). He has also held a variety of critical management roles across the industry at Eisai, Veeva, Retrophin, Gilead Sciences, Abbott Laboratories, Boehringer Ingelheim and Merck. Dr. Soliman previously also served as Vice President of Medical and Scientific Affairs at CME LLC, a leading provider of CME to health care providers nationwide. He has published extensively and led a number of initiatives focusing in the areas of ischemic heart disease, dyslipidemia, diastolic heart failure, type 2 diabetes, and obesity where he has collaborated with some of the nation's top research institutions such as the Pennington Biomedical Research Center, the Washington Center for Weight Management & Research, the Yale School of Medicine Digestive Diseases Program, and the University of Pennsylvania's Center for Weight & Eating Disorders. Dr. Soliman was most recently invited to speak at the Center for Medical Technology & Policy's (CMTP) conference on Comparative Effectiveness Research to help inform payers, healthcare policy makers, physicians and patients on the most effective ways to design clinical trials to better address gaps in medicine. He has also held several academic appointments at Seton Hall University's School of Health & Medical Sciences, New Jersey City University, Kean University's College of Natural & Applied Sciences, and Touro College of Physical Therapy & Pharmacy teaching a variety of courses including clinical therapeutics, pharmacology, pathophysiology and epidemiology. Dr. Soliman earned his Ph.D, MPHil. from Columbia University, his Bachelor's degree from New York University and a Master's Degree from St. Peter's University focused in Biochemistry & Education. He also completed post-doctoral work at Harvard University T.H. Chan School of Public Health.  William Soliman, PhD, MPhil, MA https://www.linkedin.com/in/williamsoliman1/ ACMA: https://www.medicalaffairsspecialist.org/board-certified-medical-affairs-specialist-program/ wasoliman1@gmail.com This podcast was sponsored by the ACMA. Other Pharmacy Podcast Episodes mentioned in this podcast: Breaking into the pharmaceutical industry as an MSL:   https://html5-player.libsyn.com/embed/episode/id/5508336/height/360/width/640/theme/standard/autonext/no/thumbnail/yes/autoplay/no/preload/no/no_addthis/no/direction/backward/   What is a Medical Science Liaison (MSL)?   http://html5-player.libsyn.com/embed/episode/id/4974092/height/360/width/640/theme/standard/autonext/no/thumbnail/yes/autoplay/no/preload/no/no_addthis/no/direction/backward/no-cache/true/   Certifications for pharmacists and Healthcare Professionals:   http://html5-player.libsyn.com/embed/episode/id/5007759/height/360/width/640/theme/standard/autonext/no/thumbnail/yes/autoplay/no/preload/no/no_addthis/no/direction/backward/no-cache/true/ See omnystudio.com/listener for privacy information.

Martijn Bijker was born and raised in the Netherlands where he did both his Masters and PhD in immuno-oncology. In 2007 he moved to Sydney, Australia to start his postdoc at the Garvan Institute and 4 years later transitioned to the pharmaceutical industry where he consecutively worked as a Medical Science Liaison (MSL) with Abbott, AbbVie and Amgen. He quickly realised that like him, many other PhD/Postdocs struggled to find good information to prepare themselves for the transition from academia into the pharmaceutical industry. This inspired Martijn to found his own career and coaching company.   For complete show notes, including links to items mentioned in this episode and a transcript of the podcast, visit www.phdcareerstories.com. You can also find us on social media: www.facebook.com/PhDCareerStories www.twitter.com/PhDCareerPod www.instagram.com/phdcareerstories www.linkedin.com/company/phd-career-stories

In questa puntata parliamo del trend del settore farmaceutico, delle cosiddette aziende "Blue-chip", di Clinical Research Associate (CRA), di Medical Science Liaison (MSL) e di quali aziende assumono entry level!☞ ​ENTRA in contatto con Giulio su Linkedin (specificando che lo hai aggiunto dopo aver ascoltato il podcast) > http://bit.ly/linkedin-giulio☞ ​HAI DOMANDE per Giulio o per un altro ospite del podcast? Falla qui > http://bit.ly/CNF-domande☞ ​LEGGI i consigli di Giulio su come creare un CV Dinamite > http://bit.ly/cv-dinamite☞ ​SEGUI i miei videocoaching gratuiti sulla vita da CRA e scopri se questo lavoro fa per te > http://bit.ly/videocralife☞ ​PARTECIPA al webinar gratuito sul ruolo del CRA e sulle date del Missione CRA 2017 in programma lunedì 5 Dicembre 2016 > http://bit.ly/webinar-cra-5-dic ☞ ​SEGUI il podcast sulla pagina facebook in modo da ricevere notifica sui prossimi ospiti che intervisterò e poter fare le tue domande > https://www.facebook.com/carrieranelfarmaceutico/☞ ​RICORDA di lasciare una recensione su iTunes :)

In questa puntata parliamo del trend del settore farmaceutico, delle cosiddette aziende "Blue-chip", di Clinical Research Associate (CRA), di Medical Science Liaison (MSL) e di quali aziende assumono entry level!☞ ​ENTRA in contatto con Giulio su Linkedin (specificando che lo hai aggiunto dopo aver ascoltato il podcast) > http://bit.ly/linkedin-giulio☞ ​HAI DOMANDE per Giulio o per un altro ospite del podcast? Falla qui > http://bit.ly/CNF-domande☞ ​LEGGI i consigli di Giulio su come creare un CV Dinamite > http://bit.ly/cv-dinamite☞ ​SEGUI i miei videocoaching gratuiti sulla vita da CRA e scopri se questo lavoro fa per te > http://bit.ly/videocralife☞ ​PARTECIPA al webinar gratuito sul ruolo del CRA e sulle date del Missione CRA 2017 in programma lunedì 5 Dicembre 2016 > http://bit.ly/webinar-cra-5-dic ☞ ​SEGUI il podcast sulla pagina facebook in modo da ricevere notifica sui prossimi ospiti che intervisterò e poter fare le tue domande > https://www.facebook.com/carrieranelfarmaceutico/☞ ​RICORDA di lasciare una recensione su iTunes :)

Today we are going to talk about the medical science liaison role, specifically from the perspective of medical writing—how can medical writers explore MSL work as a career option. Our guest is Dr. Jennifer Williams. Jennifer holds a law degree from Western Michigan University Law School. She also brings twenty-five years of experience working within the healthcare industry. She has been both a Medical Science Liaison (MSL) and has implemented an MSL program. Dr. Williams serves on the Advisory Committee for the MSL Society and currently she represents Nascent Medical as our MSL Advisor. CONTENT 1:30: Understanding what knowledge is needed for MSLs (hint: regulatory and business). Also needed, scientific acumen, verbal and written communication skills. 3.20: How does MSL work differ from that of being a salesperson? 4.08: Metric, access time, used for measuring MSL interaction with KOLs 4.53: What does an MSL do? 5.30: Different types of MSLs: outcomes MSL; pharma MSL; medical device MSLs; publication MSL; multifunction MSLs 9.00: How are MSLs perceived by clinicians? 11.07: What steps should medical writers do to get a job with a company as an MSL? 12.41: Occupational outlook of MSLs (it’s good) 13.25: One crucial action needed for MSL interview success 15:02: MSL society – benefits of membership 16:40: Communication skills in MSLs 17:35: How do I approach people who would hire an MSL? 18:29: difference between MSL role and clinical manager role 18:55: What do MSLs get paid? 19:42: A question she often gets: Why are sales people sometimes not allowed to go on KOL visits with MSLs?